ANTHONY GREGG LAPOINTE

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Gregg A. Lapointe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANTHONY GREGG LAPOINTE:

Company Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 12,500 $238,250 $19.06 23 May 2025 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26,550 11 Jun 2025 Direct
SOLIGENIX, INC. Director Stock Option (Right to Buy) 17,647 20 Jun 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3,000 23 May 2025 Direct

Insider Reports Filed by ANTHONY GREGG LAPOINTE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNGX SOLIGENIX, INC. 20 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:34
ATXS Astria Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:12
RIGL RIGEL PHARMACEUTICALS INC 23 May 2025 2 $0 4 Director 28 May 2025, 17:27
SNGX SOLIGENIX, INC. 12 Dec 2024 1 $0 4 Director 13 Dec 2024, 16:23
ATXS Astria Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:07
RIGL RIGEL PHARMACEUTICALS INC 25 May 2024 2 $0 4 Director 29 May 2024, 19:20
SNGX SOLIGENIX, INC. 15 Dec 2023 1 $0 4 Director 15 Dec 2023, 16:10
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Director 06 Jun 2023, 08:06
RIGL RIGEL PHARMACEUTICALS INC 26 May 2023 2 $0 4 Director 12 Jul 2023, 18:45
SNGX SOLIGENIX, INC. 17 Nov 2022 1 $0 4 Director 21 Nov 2022, 15:30
ATXS Astria Therapeutics, Inc. 09 Jun 2022 1 $0 4/A Director 21 Jun 2022, 08:32
RIGL RIGEL PHARMACEUTICALS INC 20 May 2022 2 $0 4 Director 23 May 2022, 17:50
SNGX SOLIGENIX, INC. 23 Sep 2021 1 $0 4 Director 24 Sep 2021, 16:21
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Director 02 Jun 2021, 19:13
RIGL RIGEL PHARMACEUTICALS INC 19 May 2021 2 $0 4 Director 21 May 2021, 20:55